These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22672535)

  • 1. Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008).
    Xhaard A; Lanternier F; Porcher R; Dannaoui E; Bergeron A; Clement L; Lacroix C; Herbrecht R; Legrand F; Mohty M; Michallet M; Cordonnier C; Malak S; Guyotat D; Couderc LJ; Socié G; Milpied N; Lortholary O; Ribaud P
    Clin Microbiol Infect; 2012 Oct; 18(10):E396-400. PubMed ID: 22672535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
    Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients.
    Allinson K; Kolve H; Gumbinger HG; Vormoor HJ; Ehlert K; Groll AH
    J Antimicrob Chemother; 2008 Mar; 61(3):734-42. PubMed ID: 18238891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence and risk factors of invasive fungal infection after haploidentical haematopoietic stem cell transplantation without in vitro T-cell depletion.
    Sun YQ; Xu LP; Liu DH; Zhang XH; Chen YH; Chen H; Ji Y; Wang Y; Han W; Wang JZ; Wang FR; Liu KY; Huang XJ
    Clin Microbiol Infect; 2012 Oct; 18(10):997-1003. PubMed ID: 22085092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
    Kulkarni S; Powles R; Sirohi B; Treleaven J; Saso R; Horton C; Atra A; Ortin M; Rudin C; Goyal S; Sankpal S; Meller S; Pinkerton CR; Mehta J; Singhal S
    Bone Marrow Transplant; 2003 Jul; 32(2):165-70. PubMed ID: 12838281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Audit of peripheral stem cell transplantation for aplastic anemia in multitransfused infected patients.
    Seth T; Kanga U; Sood P; Sharma V; Mishra P; Mahapatra M
    Transplant Proc; 2012 May; 44(4):922-4. PubMed ID: 22564586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of non-Candida fungal blood isolation in patients undergoing high-risk allogeneic hematopoietic stem cell transplantation (1993-2001).
    Safdar A; Singhal S; Mehta J
    Cancer; 2004 Jun; 100(11):2456-61. PubMed ID: 15160352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation.
    Leithauser M; Kahl C; Aepinus C; Prall F; Maruschke M; Riemer H; Wolff D; Jost K; Hilgendorf I; Freund M; Junghanss C
    Transpl Infect Dis; 2010 Jun; 12(3):251-7. PubMed ID: 20002357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention.
    Safdar A; Rodriguez GH; Mihu CN; Mora-Ramos L; Mulanovich V; Chemaly RF; Champlin RE; Khouri I
    Bone Marrow Transplant; 2010 Feb; 45(2):339-47. PubMed ID: 19561648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
    Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
    Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q; Dong M; Wang QM; Wen JY; Wu XY
    Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unrelated cord blood transplant experience by the pediatric blood and marrow transplant consortium.
    Yu LC; Wall DA; Sandler E; Chan KW; Grayson G; Kletzel M
    Pediatr Hematol Oncol; 2001 Jun; 18(4):235-45. PubMed ID: 11400647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.
    Cordonnier C; Ribaud P; Herbrecht R; Milpied N; Valteau-Couanet D; Morgan C; Wade A;
    Clin Infect Dis; 2006 Apr; 42(7):955-63. PubMed ID: 16511759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of invasive aspergillosis in allogeneic stem cell transplant recipients receiving amphotericin B inhalation prophylaxis.
    Nihtinen A; Anttila VJ; Ruutu T; Juvonen E; Volin L
    Transpl Infect Dis; 2012 Feb; 14(1):24-32. PubMed ID: 21749589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
    Lanternier F; Dannaoui E; Morizot G; Elie C; Garcia-Hermoso D; Huerre M; Bitar D; Dromer F; Lortholary O;
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S35-43. PubMed ID: 22247443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucormycosis: a new concern in the transplant ward?
    Robin C; Alanio A; Cordonnier C
    Curr Opin Hematol; 2014 Nov; 21(6):482-90. PubMed ID: 25295745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal rhizopus pneumonia in allogeneic stem cell transplant patients despite posaconazole prophylaxis: two cases and review of the literature.
    Lekakis LJ; Lawson A; Prante J; Ribes J; Davis GJ; Monohan G; Baraboutis IG; Skoutelis AT; Howard DS
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):991-5. PubMed ID: 19589489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
    Ito JI; Chandrasekar PH; Hooshmand-Rad R
    Bone Marrow Transplant; 2005 Nov; 36(10):873-7. PubMed ID: 16113663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of HLA-E polymorphisms in graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell transplantation.
    Hosseini E; Schwarer AP; Ghasemzadeh M
    Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):15-21. PubMed ID: 22427472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis.
    Jantunen E; Nihtinen A; Volin L; Juvonen E; Parkkali T; Ruutu T; Anttila VJ
    Bone Marrow Transplant; 2004 Nov; 34(10):891-5. PubMed ID: 15517009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.